Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.070
-0.010 (-0.93%)
At close: Dec 10, 2025, 4:00 PM EST
1.080
+0.010 (0.93%)
After-hours: Dec 10, 2025, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $107.2 million as of December 10, 2025. Its market cap has decreased by -15.65% in one year.
Market Cap
107.20M
Enterprise Value
98.90M
1-Year Change
-15.65%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $107.20M, an increase of 53.66%. That is a compound annual growth rate of 6.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 107.20M | 2.17% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | 71.68M | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.59B |
| Johnson & Johnson | 496.48B |
| AbbVie | 397.10B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 279.37B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.56B |
| Thermo Fisher Scientific | 215.09B |